NewAmsterdam Pharma Corporation
NewAmsterdam Pharma is a late-stage clinical biopharmaceutical company focused on developing transformative therapies for cardiovascular disease and other lipid-related and cardiometabolic conditions. The company is advancing science-backed, patient-focused treatments, including its investigational CETP inhibitor obicetrapib, to help patients whose needs are not met by currently available lipid-lowering therapies.
NewAmsterdam Pharma is a late-stage clinical biopharmaceutical company focused on developing transformative therapies for cardiovascular disease and other lipid-related and cardiometabolic conditions. The company is advancing science-backed, patient-focused treatments, including its investigational CETP inhibitor obicetrapib, to help patients whose needs are not met by currently available lipid-lowering therapies.
Bouw aan je carrière op Magnet.me
Maak een profiel aan en ontvang connectieverzoeken van geïnteresseerde bedrijven.
Vacatures
Interessant om te weten
Deze bedrijfspagina is automatisch gegenereerd en bevat daarom nog weinig informatie. Je vindt meer informatie over NewAmsterdam Pharma Corporation op hun website:
Deze bedrijfspagina is automatisch gegenereerd en bevat daarom nog weinig informatie. Je vindt meer informatie over NewAmsterdam Pharma Corporation op hun website: